Date : 23-Dec-2020
The LipiFlow Dry Eye treatment is basically for those patients who are suffering from mild, moderate, or severe dry eyes. Researches have shown that the primary cause of Dry Eye is a condition known as Meibomian Gland Dysfunction (MGD). To clear the gland blockages from MGD, thermal pulsation treatment is used by massaging & gently heating the inner and outer lid. LipiFlow is the only FDA-cleared device that provides both inner & outer lid therapy. It is specifically designed to remove blockages from the Meibomian glands and facilitate their functioning.
LipiFlow treatment effectively removes blockages of the meibomian gland. It is done using a patented algorithm of heat applied to the inner eyelids & massage. To improve gland function and reduce the progression of MGD, removal of gland blockages becomes essential.
The LipiFlow treatment is performed on both eyes for a specified period (12-15 minutes). The object is to melt the hardened meibum using heat and massage and evacuate the glands with pulsating massage.
No. Before starting the treatment, a numbing drop is applied to the patient’s eyes. The treatment includes the insertion of a disposable scleral cup that safeguards the actual eye from direct heat or pulsation. Hence cornea remains protected during the treatment.
Yes, you may resume your daily activities immediately after the treatment. You will not need a second person to accompany you.
Amrit Hospital is India’s one of the most renowned hospitals that provide LipiFlow treatment using advanced techniques. To know more, visit…….
Blog reviewed by: Dr. Lalit Kumar
Mail Us: firstname.lastname@example.org
Book an appointment below
Amrit Hospital was conceptualized with an aim to strive to provide patients with a safe place to get treated. We strive to put our patients’ comfort and treatability above our own concerns. Therefore, we stress on using the latest technology in terms of biomedical equipment, laboratory, surgeries, etc. Amrit Hospital has opted for the latest in LASIK technologies to fight the ophthalmological issues that affect the majority of the patients.